Education and Training Resources
Members Only Login
Print this pageSymposium Webcast
|
|
Date of Release: September 30, 2007 Jointly sponsored by FCG and Acumentis | |
Overview
This activity will provide a simplified overview of surgical hemostasis and information about the effects of coagulation impairment on perioperative hemostasis.
|
|
to obtain your CME certificate.Target Audience
Immune-Induced Vascular Complications: HIT and Beyond is intended for vascular surgeons and other health care professionals who have an interest in surgical hemostasis.
Educational Objectives
After completing this continuing medical education (CME) activity, participants should be able to:
- Explain key aspects of the biology of surgical hemostasis and its management
- Describe the pathophysiology of inhibitor development in heparin-treated patients
- Describe how antibodies to factor V and thrombin may form in patients who have been exposed to bovine thrombin
- Evaluate the therapeutic approaches to prevention and management of patients with treatment-induced inhibitors
Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The FCG Institute for Continuing Education and Acumentis. The FCG Institute for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The FCG Institute for Continuing Education designates this educational activity for a maximum of 1.5 AMA
PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
How to Get Your CME Credit
To receive credit for this CME activity, participants must listen to the online presentation, complete the evaluation and credit request form, and score 70% or higher on the posttest. Mail these forms to: The FCG Institute for Continuing Education-(101013) 1140 Welsh Road, Suite 210, North Wales, PA 19454-2046; or fax to (215) 412-9686. A certificate will be mailed to you within 4 weeks of our receipt of the completed forms. Forms must be submitted by September 30, 2008.
Disclosure
It is the policy of The FCG Institute for Continuing Education that all faculty participating in CME activities are expected to disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentations and (2) discussion of unlabeled or unapproved uses of drugs or medical devices.
Conflict of Interest Resolution
When individuals in a position to control or influence the development of the content have reported Financial Relationships with one or more commercial interests, The FCG Institute for Continuing Education utilizes a process to identify and resolve potential conflicts to ensure that the content presented is free of commercial bias. The content of this presentation was vetted through The FCG Institute’s process of peer review and content validation and modified as required to meet this standard.
Faculty Disclosures
Jeffrey H. Lawson, MD, PhD
Activity Chairman
Associate Professor of Surgery
Duke University Medical Center
Durham, North Carolina
Biographical SketchJeffrey H. Lawson, MD, PhD, received his medical degree and a PhD in cell and molecular biology from the University of Vermont in Burlington. He then completed a postdoctoral fellowship in biochemistry at the same location and a residency in general and thoracic surgery and a fellowship in vascular surgery at the Duke University Medical Center in Durham, North Carolina.
Dr. Lawson is Associate Professor of Surgery and Assistant Professor of Pathology at the Duke University Medical Center, where he is also Director of the Vascular Surgery Research Laboratory and Director of Clinical Trials in Vascular Surgery.
Dr. Lawson is an ad hoc reviewer for Annals of Thoracic Surgery and American Journal of Kidney Diseases. He is the author of several dozen journal articles and abstracts and an international lecturer. Dr. Lawson is a council member of both Cardiovascular Surgery and Arteriosclerosis, Thrombosis, and Vascular Biology of the American Heart Association and a cofounder and secretary for the Vascular Access Society of the Americas.
Faculty Disclosure Statement
Dr. Lawson has disclosed that he has served as principal investigator for Ark Therapeutics Group plc, Atrium Medical Corporation, Baxter International Inc., Endologix, Inc., GraftCath, Inc., Hemoscience Corporation, Lemaitre Vascular, Inc., Pervasive Therapeutics, Inc., and ZymoGenetics, Inc. He has served on the advisory board for Humacyte and has been an expert reviewer for Johnson & Johnson and a speaker for GlaxoSmithKline.
Jerrold H. Levy, MD
Professor of Anesthesiology
Deputy Chairman for Research
Department of Anesthesiology
Emory University School of Medicine
Director of Cardiothoracic Anesthesiology
Attending Physician, Cardiothoracic Intensive Care Unit
Emory University Hospital
Atlanta, Georgia
Biographical SketchJerrold H. Levy, MD, received his medical degree from the University of Miami in Miami, Florida. After serving a postdoctoral internship in internal medicine at Jackson Memorial Hospital in Miami, he completed a residency in the Department of Anesthesia at Massachusetts General Hospital, Boston, where he was also chief resident. He also completed 2 fellowships there, the first in cardiac anesthesia and the second in respiratory intensive care.
Dr. Levy is Professor of Anesthesiology and Deputy Chairman for Research in the Department of Anesthesiology at Emory University School of Medicine in Atlanta, Georgia. He is also Director of Cardiothoracic Anesthesiology and an Attending Physician in the Cardiothoracic Intensive Care Unit at Emory University Hospital.
Dr. Levy is a member of the Leadership Committee of the Council on Cardiovascular Surgery and Anesthesia of the American Heart Association and an elected member of the Association of Cardiac Anesthesiologists, the European Society of Intensive Care Medicine, and the Shock Society. He has served on the editorial board of Anesthesiology, is currently Section Editor for Hemostasis and Transfusion Medicine for Anesthesia & Analgesia, and is on the board of the Journal of Cardiothoracic and Vascular Anesthesia and the Heart Surgery Forum. He also serves as a consultant reviewer for many other journals in the areas of hemostasis, inflammation, anaphylaxis, and anesthesiology. He is the recipient of multiple awards, including the Harvard Prize Book Award, American Cancer Society Research Fellowship, M. Jasinska Anesthesia Award from Massachusetts General Hospital, and the 3M New Investigator Award.
Dr. Levy’s research interests include hemostasis, acute inflammation and anaphylactic reactions, cardiovascular pharmacology, and vascular physiology. He has been active in developing transfusion alternatives and elucidating mechanisms involved in anaphylactic shock. Some of his current research efforts include applying biotechnology in clinical medicine, understanding mechanisms of thrombin signaling, and developing novel anticoagulation and reversal strategies. Dr. Levy has written 2 textbooks, edited several others, and published over 300 journal articles, reviews, abstracts, monographs, textbooks, textbook chapters, editorials, and other publications.
Faculty Disclosure Statement
Dr. Levy has disclosed that he has received research support from Alexion Pharmaceuticals and Novo Nordisk Inc. and has served as a consultant to Bayer HealthCare AG, Medco, and Novo Nordisk Inc.
Howard A. Liebman, MD
Division Chief
Division of Hematology
Keck School of Medicine
University of Southern California
Los Angeles, California
Biographical SketchHoward A. Liebman, MD, received his medical degree from the University of Southern California in Los Angeles, California. He then completed an internship and residency in internal medicine, fellowships in oncology and hematology at the LAC+USC Medical Center in Los Angeles, and a research fellowship in immunochemistry and coagulation chemistry at the New England Medical Center at Tufts University in Boston, Massachusetts.
Dr. Liebman is Division Chief of the Division of Hematology at the Keck School of Medicine at the University of Southern California, where he is Professor of Medicine and Pathology and Director of the Fellowship Program in Hematology. Dr. Liebman is also Medical Director of the Hemostasis Laboratory of the Norris Cancer Hospital in Los Angeles.
Dr. Liebman is an international lecturer and the author of over 80 journal articles and textbook chapters. He is a reviewer for more than a dozen publications, including Annals of Rheumatic Diseases, Archives of Internal Medicine, Blood, and Journal of Clinical Oncology. Dr. Liebman is the creator of a process dealing with immunoaffinity purification of proteins and is a member of the American Society of Hematology, the American College of Physicians, and the International Society on Thrombosis and Haemostasis, among others.
Faculty Disclosure Statement
Dr. Liebman has disclosed that he has received grant and research support from Amgen Inc., Bristol-Myers Squibb Company, and Pharmion Corporation. He has served on advisory boards for Baxter HealthCare AG, Bristol-Myers Squibb Company, and Ortho-Biotech Products, L.P. and has been a speaker for GlaxoSmithKline and Pharmion Corporation.
Notice About Investigational or Off-Label Use
This educational activity may include discussion of drugs or devices or uses of drugs and devices that have not been approved by the FDA or have been approved by the FDA for specific uses only. It is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. The FCG Institute for Continuing Education is committed to the free exchange of medical education. Inclusion of any product or device discussion, including discussion of investigational or off-label uses, does not imply endorsement by The FCG Institute of the uses, products, or techniques presented.
Disclaimer
This CME activity is designed for use by health care professionals for educational purposes only. The information and opinions expressed by the faculty are their own and do not necessarily reflect those of The FCG Institute. The FCG Institute for Continuing Education neither defines a standard of care nor intends to dictate an exclusive course of management but presents, through the educational programs it sponsors, recognized methods and techniques of clinical practice that physicians and other health care providers can consider incorporating into their practices. Participants should use their own clinical judgment before applying information, whether provided here or by others, for any professional use.
|
|
Society for Vascular Surgery - 633 N. St. Clair, 24th Floor; Chicago, IL 60611; Phone: 312-334-2300 or 800-258-7188; Fax: 312-334-2320; Email: vascular@vascularsociety.org
© 2008 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.
© 2008 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.